腫瘤學人工智慧市場規模、佔有率和趨勢分析報告：按組件類型、癌症類型、應用、最終用途、地區和細分市場預測（2026-2033 年）

AI In Oncology Market Size, Share & Trends Analysis Report By Component Type, By Cancer Type, By Application, By End Use, By Region, And Segment Forecasts, 2026 - 2033

出版日期: 2025年12月22日 | 出版商:

Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

腫瘤學人工智慧市場概覽

2025年全球腫瘤學人工智慧市場規模估計為60億美元，預計2033年將達到389.1億美元。

預計從 2026 年到 2033 年，該市場將以 24.77% 的複合年成長率成長。市場成長歸因於癌症發病率的上升、癌症診斷技術和醫療保健基礎設施的進步，以及對癌症早期檢測和分類需求的不斷成長。

此外，精準醫療的日益普及進一步推動了市場成長。全球癌症發生率的上升促使腫瘤領域更加依賴人工智慧。根據美國國立衛生研究院 (美國) 的預測，到 2023 年，美國將有約 200 萬人被診斷出罹患癌症。乳癌是最常見的癌症，估計女性病例為 297,790 例，男性病例為 2,800 例。攝護腺癌是男性最常見的癌症，也是所有癌症中第二常見的癌症，估計病例為 288,300 例。肺癌和支氣管癌是第三常見的癌症，估計值病例為 288,300 例。

公共和私營機構加大研發投入，尤其是在引進新技術方面，預計將進一步推動市場成長。例如，2022年10月，專注於精準醫療和人工智慧的Tempus公司宣布推出「Tempus+」計畫。本計畫利用真實世界數據推進合作進行的精準腫瘤學研究。包括貝勒醫學院、阿勒格尼健康網路、史丹佛癌症中心、拉什大學醫學中心和TriHealth在內的研究機構已在使用Tempus+計畫進行研究。此外，人工智慧相關醫療設備產品核可的增加預計也將推動市場成長。 2024年1月，美國FDA核准了首款用於皮膚癌檢測的人工智慧醫療設備DermaSensor。

人工智慧在腫瘤學領域的應用有望在早期檢測、精準醫療和個人化治療方案方面取得突破性進展。人工智慧能夠分析大量資料集、識別細微模式並提供即時洞察，這有望徹底改變癌症的診斷和治療方式，開啟患者預後改善和醫療服務效率提升的新時代。

The global AI in oncology market size was estimated at USD 6.00 billion in 2025 and is expected to reach USD 38.91 billion by 2033, growing at a CAGR of 24.77% from 2026 to 2033. The growth of the market is attributed to increasing prevalence of cancer, technological advancement in cancer diagnostics & healthcare infrastructure, and an increasing demand for early detection and classification of cancer.

In addition, rising adoption of precision medicine is drives market growth further. The increasing incidence of cancer globally has led to a growing dependence on AI in the field of oncology. According to the NIH estimates of 2023, approximately 2.0 million individuals in the U.S. are diagnosed with cancer. Breast cancer was the most diagnosed cancer, with an estimated 297,790 cases in women and 2,800 cases in men. Among men, prostate cancer was the most frequently diagnosed cancer, and overall, it was the second most common diagnosis, with an anticipated 288,300 cases. The estimated number of new cases of lung and bronchus cancer made it the third most diagnosed cancer.

The growing initiatives undertaken by public and private organizations to invest in research and development (R&D) for introduction of novel technologies are further anticipated to fuel growth of the market. For instance, in October 2022, Tempus, a company specializing in precision medicine and AI, recently announced a program called Tempus+. This proprietary program utilizes real-world data to power collaborative precision oncology research. A community of researchers, including Baylor College of Medicine, Allegheny Health Network, Stanford Cancer Center, Rush University Medical Center, TriHealth, and others, is already using the Tempus+ program to advance their research. Furthermore, increasing product approval of AI-associated medical devices is anticipated to boost market growth. In January 2024, the U.S. FDA approved the first AI medical device, DermaSensor, to detect skin cancer.

The future of AI applications in cancer care is poised for groundbreaking advancements, encompassing early detection, precision medicine, and personalized treatment plans. AI's ability to analyze vast datasets, identify subtle patterns, and provide real-time insights holds the potential to revolutionize cancer diagnosis and therapy, ushering in a new era of improved patient outcomes and more efficient healthcare delivery.

Global AI In Oncology Market Report Segmentation

This report forecasts revenue growth and provides at global, regional, and country levels an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global AI in oncology market report based on component type, cancer type, application, end use, and region:

Component Type Outlook (Revenue, USD Million, 2021 - 2033)
Software Solutions
Hardware
Services
Cancer Type Outlook (Revenue, USD Million, 2021 - 2033)
Breast Cancer
Lung Cancer
Prostate Cancer
Colorectal Cancer
Brain Tumor
Others
Application Outlook (Revenue, USD Million, 2021 - 2033)
Diagnostics (Pathology, Cancer Radiology)
Radiation therapy (Radiotherapy)
Research & Development (Drug design, development process, etc.)
Chemotherapy
Immunotherapy
End Use Type Outlook (Revenue, USD Million, 2021 - 2033)
Hospitals
Surgical Centers & Medical Institutes
Others (Pharmaceutical companies, Research institutes & training centers)
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
- U.S.
- Canada
Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- Japan
- China
- India
- South Korea
- Australia
- Thailand
Latin America
- Brazil
- Mexico
- Argentina
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Chapter 1. Methodology and Scope

1.1 Market Segmentation and Scope
- 1.1.1 Segment scope
- 1.1.2 Regional scope
- 1.1.3 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
- 1.3.1 Purchased database:
- 1.3.2 GVR's internal database
- 1.3.3 Secondary sources
- 1.3.4 Primary research
- 1.3.5 Details of primary research
1.4 Information or Data Analysis
- 1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
- 1.6.1 Commodity Flow Analysis
  - 1.6.1.1 Approach: Commodity Flow Approach
1.7 Research Assumptions
1.8 List of Secondary Sources
1.9 List of Abbreviations

Chapter 2. Executive Summary

2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights

Chapter 3. AI In Oncology Market Variables, Trends, & Scope

3.1 Market Lineage Outlook
- 3.1.1 Parent market sanalysis
3.2 Market Dynamics
- 3.2.1 Market drivers analysis
- 3.2.2 Market restraint analysis
- 3.2.3 Market opportunity analysis
- 3.2.4 Market challenges analysis
3.3 AI In Oncology: Market Analysis Tools
- 3.3.1 Industry analysis - Porter's Five Forces Analysis
- 3.3.2 PESTLE analysis
3.4 Case studies

Chapter 4. AI In Oncology Market Segment Analysis, By Component Type, 2021 - 2033 (USD Million)

4.1 Definition and Scope
4.2 Component Type Market Share Analysis, 2025 & 2033
4.3 Segment Dashboard
4.4 Global AI In Oncology Market, by Component, 2021 to 2033
4.5 Software Solutions
- 4.5.1 Software solutions market estimates and forecast, 2021 - 2033 (USD Million)
4.6 Hardware
- 4.6.1 Hardware market estimates and forecast, 2021 - 2033 (USD Million)
4.7 Services
- 4.7.1 Services market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 5. AI In Oncology Market Segment Analysis, By Cancer Type, 2021 - 2033 (USD Million)

5.1 Definition and Scope
5.2 Cancer Type Market Share Analysis, 2025 & 2033
5.3 Segment Dashboard
5.4 Global AI In Oncology Market, by Cancer Type, 2021 to 2033
5.5 Breast Cancer
- 5.5.1 Breast cancer market estimates and forecast, 2021 - 2033 (USD Million)
5.6 Lung Cancer
- 5.6.1 Lung cancer market estimates and forecast, 2021 - 2033 (USD Million)
5.7 Prostate Cancer
- 5.7.1 Prostate cancer market estimates and forecast, 2021 - 2033 (USD Million)
5.8 Colorectal Cancer
- 5.8.1 Colorectal cancer market estimates and forecast, 2021 - 2033 (USD Million)
5.9 Brain Tumor
- 5.9.1 Brain tumor market estimates and forecast, 2021 - 2033 (USD Million)
5.10 Others
- 5.10.1 Others market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 6. AI In Oncology Market Segment Analysis, By Application, 2021 - 2033 (USD Million)

6.1 Definition and Scope
6.2 Application Market Share Analysis, 2025 & 2033
6.3 Segment Dashboard
6.4 Global AI In Oncology Market, by Application, 2021 to 2033
6.5 Diagnostics (Pathology, Cancer Radiology)
- 6.5.1 Diagnostics (pathology, cancer radiology) market estimates and forecast, 2021 - 2033 (USD Million)
6.6 Radiation Therapy (Radiotherapy)
- 6.6.1 Radiation therapy (radiotherapy) market estimates and forecast, 2021 - 2033 (USD Million)
6.7 Research & Development (Drug Design, Development Process, etc.)
- 6.7.1 Research & development (drug design, development process, etc.) market estimates and forecast, 2021 - 2033 (USD Million)
6.8 Chemotherapy
- 6.8.1 Chemotherapy market estimates and forecast, 2021 - 2033 (USD Million)
6.9 Immunotherapy
- 6.8.1 Immunotherapy market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 7. AI In Oncology Market Segment Analysis, By End Use Type, 2021 - 2033 (USD Million)

7.1 Definition and Scope
7.2 Application Market Share Analysis, 2025 & 2033
7.3 Segment Dashboard
7.4 Global AI In Oncology Market, by Application, 2021 to 2033
7.5 Hospitals
- 7.5.1 Hospitals market estimates and forecast, 2021 - 2033 (USD Million)
7.6 Surgical Centers & Medical Institutes
- 7.6.1 Surgical centers & medical institutes market estimates and forecast, 2021 - 2033 (USD Million)
7.7 Others (Pharmaceutical Companies, Research Institutes & Training Centers)
- 7.7.1 Others (pharmaceutical companies, research institutes & training centers) market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 8. AI In Oncology Market Segment Analysis, By Region, By Component, By Cancer Type, By Application, By End-use, 2021 - 2033 (USD Million)

8.1. Definition & Scope
8.2. Regional Market Share Analysis, 2025 & 2033
8.3. Regional Market Dashboard
8.4. Regional Market Snapshot
8.5. SWOT Analysis
8.6. North America
- 8.6.1. North America Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
- 8.6.2. U.S.
  - 8.6.2.1. Key Country Dynamic
  - 8.6.2.2. Regulatory Framework
  - 8.6.2.3. Competitive Insights
  - 8.6.2.4. U.S. Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
- 8.6.3. Canada
  - 8.6.3.1. Key Country Dynamic
  - 8.6.3.2. Regulatory Framework
  - 8.6.3.3. Competitive Insights
  - 8.6.3.4. Canada Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
8.7. Europe
- 8.7.1. Europe Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
- 8.7.2. Germany
  - 8.7.2.1. Key Country Dynamic
  - 8.7.2.2. Regulatory Framework
  - 8.7.2.3. Competitive Insights
  - 8.7.2.4. Germany Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
- 8.7.3. UK
  - 8.7.3.1. Key Country Dynamic
  - 8.7.3.2. Regulatory Framework
  - 8.7.3.3. Competitive Insights
  - 8.7.3.4. UK Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
- 8.7.4. France
  - 8.7.4.1. Key Country Dynamic
  - 8.7.4.2. Regulatory Framework
  - 8.7.4.3. Competitive Insights
  - 8.7.4.4. France Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
- 8.7.5. Italy
  - 8.7.5.1. Key Country Dynamic
  - 8.7.5.2. Regulatory Framework
  - 8.7.5.3. Competitive Insights
  - 8.7.5.4. Italy Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
- 8.7.6. Spain
  - 8.7.6.1. Key Country Dynamic
  - 8.7.6.2. Regulatory Framework
  - 8.7.6.3. Competitive Insights
  - 8.7.6.4. Spain Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
- 8.7.7. Denmark
  - 8.7.7.1. Key Country Dynamic
  - 8.7.7.2. Regulatory Framework
  - 8.7.7.3. Competitive Insights
  - 8.7.7.4. Denmark Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
- 8.7.8. Sweden
  - 8.7.8.1. Key Country Dynamic
  - 8.7.8.2. Regulatory Framework
  - 8.7.8.3. Competitive Insights
  - 8.7.8.4. Sweden Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
- 8.7.9. Norway
  - 8.7.9.1. Key Country Dynamic
  - 8.7.9.2. Regulatory Framework
  - 8.7.9.3. Competitive Insights
  - 8.7.9.4. Norway Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
8.8. Asia Pacific
- 8.8.1. Asia Pacific Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
- 8.8.2. Japan
  - 8.8.2.1. Key Country Dynamic
  - 8.8.2.2. Regulatory Framework
  - 8.8.2.3. Competitive Insights
  - 8.8.2.4. Japan Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
- 8.8.3. China
  - 8.8.3.1. Key Country Dynamic
  - 8.8.3.2. Regulatory Framework
  - 8.8.3.3. Competitive Insights
  - 8.8.3.4. China Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
- 8.8.4. India
  - 8.8.4.1. Key Country Dynamic
  - 8.8.4.2. Regulatory Framework
  - 8.8.4.3. Competitive Insights
  - 8.8.4.4. India Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
- 8.8.5. South Korea
  - 8.8.5.1. Key Country Dynamic
  - 8.8.5.2. Regulatory Framework
  - 8.8.5.3. Competitive Insights
  - 8.8.5.4. South Korea Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
- 8.8.6. Australia
  - 8.8.6.1. Key Country Dynamic
  - 8.8.6.2. Regulatory Framework
  - 8.8.6.3. Competitive Insights
  - 8.8.6.4. Australia Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
- 8.8.7. Thailand
  - 8.8.7.1. Key Country Dynamic
  - 8.8.7.2. Regulatory Framework
  - 8.8.7.3. Competitive Insights
  - 8.8.7.4. Thailand Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
8.9. Latin America
- 8.9.1. Latin America Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
- 8.9.2. Brazil
  - 8.9.2.1. Key Country Dynamic
  - 8.9.2.2. Regulatory Framework
  - 8.9.2.3. Competitive Insights
  - 8.9.2.4. Brazil Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
- 8.9.3. Mexico
  - 8.9.3.1. Key Country Dynamic
  - 8.9.3.2. Regulatory Framework
  - 8.9.3.3. Competitive Insights
  - 8.9.3.4. Mexico Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
- 8.9.4. Argentina
  - 8.9.4.1. Key Country Dynamic
  - 8.9.4.2. Regulatory Framework
  - 8.9.4.3. Competitive Insights
  - 8.9.4.4. Argentina Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
8.10. MEA
- 8.10.1. MEA Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
- 8.10.2. South Africa
  - 8.10.2.1. Key Country Dynamic
  - 8.10.2.2. Regulatory Framework
  - 8.10.2.3. Competitive Insights
  - 8.10.2.4. South Africa Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
- 8.10.3. Saudi Arabia
  - 8.10.3.1. Key Country Dynamic
  - 8.10.3.2. Regulatory Framework
  - 8.10.3.3. Competitive Insights
  - 8.10.3.4. Saudi Arabia Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
- 8.10.4. UAE
  - 8.10.4.1. Key Country Dynamic
  - 8.10.4.2. Regulatory Framework
  - 8.10.4.3. Competitive Insights
  - 8.10.4.4. UAE Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)
- 8.10.5. Kuwait
  - 8.10.5.1. Key Country Dynamic
  - 8.10.5.2. Regulatory Framework
  - 8.10.5.3. Competitive Insights
  - 8.10.5.4. Kuwait Healthcare AI in Oncology Market, 2021 - 2033 (USD Million)

Chapter 9. AI In Oncology Market - Competitive Analysis

9.1. Recent Developments & Impact Analysis, by Key Market Participants
9.2. Company Categorization
9.3. Company Profiles
- 9.3.1. Azra AI
  - 9.3.1.1. Overview
  - 9.3.1.2. Financial Performance
  - 9.3.1.3. Service Benchmarking
  - 9.3.1.4. Strategic Initiatives
- 9.3.2. ICAD, INC.
  - 9.3.2.1. Overview
  - 9.3.2.2. Financial Performance
  - 9.3.2.3. Service Benchmarking
  - 9.3.2.4. Strategic Initiatives
- 9.3.3. Siemens Healthcare GmbH
  - 9.3.3.1. Overview
  - 9.3.3.2. Financial Performance
  - 9.3.3.3. Service Benchmarking
  - 9.3.3.4. Strategic Initiatives
- 9.3.4. Intel Corporation
  - 9.3.4.1. Overview
  - 9.3.4.2. Financial Performance
  - 9.3.4.3. Service Benchmarking
  - 9.3.4.4. Strategic Initiatives
- 9.3.5. GE HealthCare
  - 9.3.5.1. Overview
  - 9.3.5.2. Financial Performance
  - 9.3.5.3. Service Benchmarking
  - 9.3.5.4. Strategic Initiatives
- 9.3.6. NVIDIA Corporation
  - 9.3.6.1. Overview
  - 9.3.6.2. Financial Performance
  - 9.3.6.3. Service Benchmarking
  - 9.3.6.4. Strategic Initiatives
- 9.3.7. Digital Diagnostics Inc.
  - 9.3.7.1. Overview
  - 9.3.7.2. Financial Performance
  - 9.3.7.3. Service Benchmarking
  - 9.3.7.4. Strategic Initiatives
- 9.3.8. ConcertAI
  - 9.3.8.1. Overview
  - 9.3.8.2. Financial Performance
  - 9.3.8.3. Service Benchmarking
  - 9.3.8.4. Strategic Initiatives
- 9.3.9. Median Technologies
  - 9.3.9.1. Overview
  - 9.3.9.2. Financial Performance
  - 9.3.9.3. Service Benchmarking
  - 9.3.9.4. Strategic Initiatives
- 9.3.10. PathAI
  - 9.3.10.1. Overview
  - 9.3.10.2. Financial Performance
  - 9.3.10.3. Service Benchmarking
  - 9.3.10.4. Strategic Initiatives
- 9.3.11. MVision AI
  - 9.3.11.1. Overview
  - 9.3.11.2. Financial Performance
  - 9.3.11.3. Service Benchmarking
  - 9.3.11.4. Strategic Initiatives

簡介目錄圖表

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global ai in oncology market, by region, 2021 - 2033 (USD Million)
Table 4 Global ai in oncology market, by component, 2021 - 2033 (USD Million)
Table 5 Global ai in oncology market, by cancer type, 2021 - 2033 (USD Million)
Table 6 Global ai in oncology market, by application, 2021 - 2033 (USD Million)
Table 7 Global ai in oncology market, by end use, 2021 - 2033 (USD Million)
Table 8 North America AI in oncology market, by region, 2021 - 2033 (USD Million)
Table 9 North America AI in oncology market, by component, 2021 - 2033 (USD Million)
Table 10 North America AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
Table 11 North America AI in oncology market, by application, 2021 - 2033 (USD Million)
Table 12 North America AI in oncology market, by end-use, 2021 - 2033 (USD Million)
Table 13 U.S. AI in oncology market, by component, 2021 - 2033 (USD Million)
Table 14 U.S. AI in oncology market, by application, 2021 - 2033 (USD Million)
Table 15 U.S. AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
Table 16 U.S. AI in oncology market, by end-use, 2021 - 2033 (USD Million)
Table 17 Canada AI in oncology market, by component, 2021 - 2033 (USD Million)
Table 18 Canada AI in oncology market, by application, 2021 - 2033 (USD Million)
Table 19 Canada AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
Table 20 Canada AI in oncology market, by end-use, 2021 - 2033 (USD Million)
Table 21 Europe AI in oncology market, by region, 2021 - 2033 (USD Million)
Table 22 Europe AI in oncology market, by component, 2021 - 2033 (USD Million)
Table 23 Europe AI in oncology market, by application, 2021 - 2033 (USD Million)
Table 24 Europe AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
Table 25 Europe AI in oncology market, by end-use, 2021 - 2033 (USD Million)
Table 26 Germany AI in oncology market, by component, 2021 - 2033 (USD Million)
Table 27 Germany AI in oncology market, by application, 2021 - 2033 (USD Million)
Table 28 Germany AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
Table 29 Germany AI in oncology market, by end-use, 2021 - 2033 (USD Million)
Table 30 UK AI in oncology market, by component, 2021 - 2033 (USD Million)
Table 31 UK AI in oncology market, by application, 2021 - 2033 (USD Million)
Table 32 UK AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
Table 33 UK AI in oncology market, by end-use, 2021 - 2033 (USD Million)
Table 34 France AI in oncology market, by component, 2021 - 2033 (USD Million)
Table 35 France AI in oncology market, by application, 2021 - 2033 (USD Million)
Table 36 France AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
Table 37 France AI in oncology market, by end-use, 2021 - 2033 (USD Million)
Table 38 Italy AI in oncology market, by component, 2021 - 2033 (USD Million)
Table 39 Italy AI in oncology market, by application, 2021 - 2033 (USD Million)
Table 40 Italy AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
Table 41 Italy AI in oncology market, by end-use, 2021 - 2033 (USD Million)
Table 42 Spain AI in oncology market, by component, 2021 - 2033 (USD Million)
Table 43 Spain AI in oncology market, by application, 2021 - 2033 (USD Million)
Table 44 Spain AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
Table 45 Spain AI in oncology market, by end-use, 2021 - 2033 (USD Million)
Table 46 Denmark AI in oncology market, by component, 2021 - 2033 (USD Million)
Table 47 Denmark AI in oncology market, by application, 2021 - 2033 (USD Million)
Table 48 Denmark AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
Table 49 Denmark AI in oncology market, by end-use, 2021 - 2033 (USD Million)
Table 50 Sweden AI in oncology market, by component, 2021 - 2033 (USD Million)
Table 51 Sweden AI in oncology market, by application, 2021 - 2033 (USD Million)
Table 52 Sweden AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
Table 53 Sweden AI in oncology market, by end-use, 2021 - 2033 (USD Million)
Table 54 Norway AI in oncology market, by component, 2021 - 2033 (USD Million)
Table 55 Norway AI in oncology market, by application, 2021 - 2033 (USD Million)
Table 56 Norway AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
Table 57 Norway AI in oncology market, by end-use, 2021 - 2033 (USD Million)
Table 58 Asia Pacific AI in oncology market, by region, 2021 - 2033 (USD Million)
Table 59 Asia Pacific AI in oncology market, by component, 2021 - 2033 (USD Million)
Table 60 Asia Pacific AI in oncology market, by application, 2021 - 2033 (USD Million)
Table 61 Asia Pacific AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
Table 62 Asia Pacific AI in oncology market, by end-use, 2021 - 2033 (USD Million)
Table 63 China AI in oncology market, by component, 2021 - 2033 (USD Million)
Table 64 China AI in oncology market, by application, 2021 - 2033 (USD Million)
Table 65 China AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
Table 66 China AI in oncology market, by end-use, 2021 - 2033 (USD Million)
Table 67 Japan AI in oncology market, by component, 2021 - 2033 (USD Million)
Table 68 Japan AI in oncology market, by application, 2021 - 2033 (USD Million)
Table 69 Japan AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
Table 70 Japan AI in oncology market, by end-use, 2021 - 2033 (USD Million)
Table 71 India AI in oncology market, by component, 2021 - 2033 (USD Million)
Table 72 India AI in oncology market, by application, 2021 - 2033 (USD Million)
Table 73 India AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
Table 74 India AI in oncology market, by end-use, 2021 - 2033 (USD Million)
Table 75 South Korea AI in oncology market, by component, 2021 - 2033 (USD Million)
Table 76 South Korea AI in oncology market, by application, 2021 - 2033 (USD Million)
Table 77 South Korea AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
Table 78 South Korea AI in oncology market, by end-use, 2021 - 2033 (USD Million)
Table 79 Australia AI in oncology market, by component, 2021 - 2033 (USD Million)
Table 80 Australia AI in oncology market, by application, 2021 - 2033 (USD Million)
Table 81 Australia AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
Table 82 Australia AI in oncology market, by end-use, 2021 - 2033 (USD Million)
Table 83 Thailand AI in oncology market, by component, 2021 - 2033 (USD Million)
Table 84 Thailand AI in oncology market, by application, 2021 - 2033 (USD Million)
Table 85 Thailand AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
Table 86 Thailand AI in oncology market, by end-use, 2021 - 2033 (USD Million)
Table 87 Latin America AI in oncology market, by region, 2021 - 2033 (USD Million)
Table 88 Latin America AI in oncology market, by component, 2021 - 2033 (USD Million)
Table 89 Latin America AI in oncology market, by application, 2021 - 2033 (USD Million)
Table 90 Latin America AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
Table 91 Latin America AI in oncology market, by end-use, 2021 - 2033 (USD Million)
Table 92 Brazil AI in oncology market, by component, 2021 - 2033 (USD Million)
Table 93 Brazil AI in oncology market, by application, 2021 - 2033 (USD Million)
Table 94 Brazil AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
Table 95 Brazil AI in oncology market, by end-use, 2021 - 2033 (USD Million)
Table 96 Mexico AI in oncology market, by component, 2021 - 2033 (USD Million)
Table 97 Mexico AI in oncology market, by application, 2021 - 2033 (USD Million)
Table 98 Mexico AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
Table 99 Mexico AI in oncology market, by end-use, 2021 - 2033 (USD Million)
Table 100 Argentina AI in oncology market, by component, 2021 - 2033 (USD Million)
Table 101 Argentina AI in oncology market, by application, 2021 - 2033 (USD Million)
Table 102 Argentina AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
Table 103 Argentina AI in oncology market, by end-use, 2021 - 2033 (USD Million)
Table 104 MEA AI in oncology market, by region, 2021 - 2033 (USD Million)
Table 105 MEA AI in oncology market, by component, 2021 - 2033 (USD Million)
Table 106 MEA AI in oncology market, by application, 2021 - 2033 (USD Million)
Table 107 MEA AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
Table 108 MEA AI in oncology market, by end-use, 2021 - 2033 (USD Million)
Table 109 South Africa AI in oncology market, by component, 2021 - 2033 (USD Million)
Table 110 South Africa AI in oncology market, by application, 2021 - 2033 (USD Million)
Table 111 South Africa AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
Table 112 South Africa AI in oncology market, by end-use, 2021 - 2033 (USD Million)
Table 113 Saudi Arabia AI in oncology market, by component, 2021 - 2033 (USD Million)
Table 114 Saudi Arabia AI in oncology market, by application, 2021 - 2033 (USD Million)
Table 115 Saudi Arabia AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
Table 116 Saudi Arabia AI in oncology market, by end-use, 2021 - 2033 (USD Million)
Table 117 UAE AI in oncology market, by component, 2021 - 2033 (USD Million)
Table 118 UAE AI in oncology market, by application, 2021 - 2033 (USD Million)
Table 119 UAE AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
Table 120 UAE AI in oncology market, by end-use, 2021 - 2033 (USD Million)
Table 121 Kuwait AI in oncology market, by component, 2021 - 2033 (USD Million)
Table 122 Kuwait AI in oncology market, by application, 2021 - 2033 (USD Million)
Table 123 Kuwait AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
Table 124 Kuwait AI in oncology market, by end-use, 2021 - 2033 (USD Million)

List of Figures

Fig. 1 AI in oncology market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Commodity flow analysis
Fig. 5 Parent market analysis
Fig. 6 AI in oncology Market snapshot
Fig. 7 AI in oncology Market segment snapshot
Fig. 8 AI in oncology Market segment snapshot
Fig. 9 AI in oncology Market competitive landscape snapshot
Fig. 10 Market research process
Fig. 11 Parent market outlook (USD Billion) (2025)
Fig. 12 AI in oncology market dynamics
Fig. 13 Areas of interest most likely to benefit from AI in the next 10 years
Fig. 14 Anticipated Clinical Impact: Key Areas where AI is Poised to Make a Significant Difference
Fig. 15 Comparison between AI-integrated healthcare and traditional healthcare
Fig. 16 Porter's Analysis
Fig. 17 PESTEL Analysis
Fig. 18 AI in oncology market, component outlook key takeaways (USD Million)
Fig. 19 AI in oncology market: Component movement analysis, 2025 & 2033 (USD Million)
Fig. 20 Software solutions market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 21 Hardware market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 22 Services market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 23 AI in cancer diagnostics market, cancer type outlook key takeaways (USD Million)
Fig. 24 AI in oncology market: Cancer type movement analysis, 2025 & 2033 (USD Million)
Fig. 25 Breast cancer market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 26 Lung cancer market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 27 Prostate cancer market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 28 Colorectal cancer market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 29 Brain tumor market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 30 Others market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 31 AI in cancer diagnostics market, application outlook key takeaways (USD Million)
Fig. 32 AI in oncology market: Application movement analysis, 2025 & 2033 (USD Million)
Fig. 33 Diagnostics (pathology, cancer radiology) market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 34 Radiation therapy (Radiotherapy) market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 35 Chemotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 36 Immunotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 37 Research & development market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 38 AI in oncology market, end-use outlook key takeaways (USD Million)
Fig. 39 AI in oncology market: End-user movement analysis, 2025 & 2033 (USD Million)
Fig. 40 Hospitals market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 41 Surgical centers and medical institutes market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 42 Others market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 43 Regional marketplace: Key takeaways
Fig. 44 AI in Oncology market: Regional outlook, 2025 & 2033 (USD Million)
Fig. 45 AI in Oncology market: Regional outlook, 2025 & 2033 (USD Million)
Fig. 46 North America AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 47 Key country dynamics
Fig. 48 U.S. AI in oncology market estimates and forecasts, 2021 - 2033 (USD billion)
Fig. 49 U.S. AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 50 Key country dynamics
Fig. 51 Canada AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 52 Europe AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 53 Key country dynamics
Fig. 54 UK AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 55 Key country dynamics
Fig. 56 Germany AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 57 Key country dynamics
Fig. 58 Spain AI In oncology market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 59 Key country dynamics
Fig. 60 France AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 61 Key country dynamics
Fig. 62 Italy AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million )
Fig. 63 Key country dynamics
Fig. 64 Norway AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 65 Key country dynamics
Fig. 66 Denmark AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 67 Key country dynamics
Fig. 68 Sweden AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 69 Asia Pacific AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million )
Fig. 70 Key country dynamics
Fig. 71 Japan AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 72 Key country dynamics
Fig. 73 China AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 74 Key country dynamics
Fig. 75 India AI In oncology market estimates and forecasts, 2021 - 2033 (USD Million )
Fig. 76 Key country dynamics
Fig. 77 Australia AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million )
Fig. 78 Key country dynamics
Fig. 79 South Korea AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million )
Fig. 80 Key country dynamics
Fig. 81 Thailand AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 82 Latin America AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million )
Fig. 83 Key country dynamics
Fig. 84 Brazil AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 85 Key country dynamics
Fig. 86 Mexico AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million )
Fig. 87 Key country dynamics
Fig. 88 Argentina AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million )
Fig. 89 MEA AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 90 Key country dynamics
Fig. 91 South Africa AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 92 Key country dynamics
Fig. 93 Saudi Arabia AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 94 Key country dynamics
Fig. 95 UAE AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 96 Key country dynamics
Fig. 97 Kuwait AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 98 Key company categorization
Fig. 99 Heat map analysis